Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan

被引：0
|
作者：
Fumitaka Suzuki
Tetsuya Hosaka
Yoshiyuki Suzuki
Hitomi Sezaki
Norio Akuta
Shunichiro Fujiyama
Yusuke Kawamura
Masahiro Kobayashi
Satoshi Saitoh
Yasuji Arase
Kenji Ikeda
Mariko Kobayashi
Rie Mineta
Yukiko Suzuki
Hiromitsu Kumada
机构：
[1] Toranomon Hospital,Department of Hepatology
[2] Okinaka Memorial Institute for Medical Research,Research Institute for Hepatology
[3] Toranomon Branch Hospital,undefined
来源：
Journal of Gastroenterology | 2019年 / 54卷
关键词：
Hepatitis B virus; Entecavir; HBsAg seroclearance; Resistance; Viral breakthrough;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：182 / 193
页数：11
相关论文
共 50 条
  • [21] Entecavir for the long-term treatment of chronic hepatitis B
    Gonzalez, Stevan A.
    Keeffe, Emmet B.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (09) : 1053 - 1062
  • [22] Efficacy of entecavir treatment among chronic hepatitis B nucleos(t)ide-naive and -experienced patients
    Bicer, Kadir Cagatay
    Ari, Alpay
    Genc, Vecdi Evren
    Caymaz, Sibel Ozsu
    Avci, Meltem
    Bal, Fatma
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2015, 45 (01) : 99 - 104
  • [23] Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t) ide-naive patients with chronic hepatitis B
    Kwon, Y. J.
    Lee, H. S.
    Park, M. J.
    Shim, S. G.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2015, 18 (06) : 796 - 801
  • [24] Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B
    Dogan, Umit Bilge
    Kara, Banu
    Gumurdulu, Yuksel
    Soylu, Aliye
    Akin, Mustafa Salih
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2012, 23 (03): : 247 - 252
  • [25] Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
    Kim, Soon Sun
    Cheong, Jae Youn
    Cho, Sung Won
    GUT AND LIVER, 2011, 5 (03) : 278 - 287
  • [26] Pre-existing mutations related to tenofovir in chronic hepatitis B patients with long-term nucleos(t)ide analogue drugs treatment by ultra-deep pyrosequencing
    Zhang, Xiaxia
    Li, Minran
    Xi, Hongli
    Zhang, Renwen
    Chen, Jianhong
    Zhang, Yu
    Xu, Xiaoyuan
    ONCOTARGET, 2016, 7 (43) : 70264 - 70275
  • [27] Nucleos(t)ide analogues therapy for chronic hepatitis B in Taiwan: Short-term versus long-term
    Peng C.-Y.
    Current Hepatitis Reports, 2013, 12 (3) : 181 - 187
  • [28] 48 weeks outcome after cessation of nucleos(t)ide analogue therapy in chronic hepatitis B patients
    Gao, Li
    Hu, Yue
    Shi, Xiaofeng
    Li, Xin
    Zhang, Dazhi
    Ren, Hong
    ANNALS OF HEPATOLOGY, 2020, 19 (03) : 329 - 334
  • [29] Long-term clinical outcome of HBeAg-negative chronic hepatitis B patients who discontinued nucleos(t)ide analogues
    Manolakopoulos, Spilios
    Kranidioti, Hariklia
    Kourikou, Anastasia
    Deutsch, Melanie-Maria
    Triantos, Christos
    Tsolias, Chrysostomos
    Manesis, Emanuel K.
    Mathou, Nicoletta
    Alexopoulou, Alexandra
    Hadziyannis, Emilia
    Papatheodoridis, George
    LIVER INTERNATIONAL, 2021, 41 (01) : 48 - 57
  • [30] Nucleos(t)ide analogues for hepatitis B virus: Strategies for long-term success
    Chien, Rong-Nan
    Liaw, Yun-Fan
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2008, 22 (06) : 1081 - 1092
12345